COVID-19: addressing the global health crisis
USP is playing a critical role in helping to accelerate the work of scientists and manufacturers developing vaccines and treatments in response to Coronavirus (COVID-19), supporting front line workers impacted by shortages of critical materials and helping to build a more resilient global medicines supply chain. Read about our efforts and how we can support you. View updates on USP Reference Standards and additional resources.
Staffed by more than 155 scientific, quality assurance, and support staff professionals, USP-India’s Hyderabad site supports USP’s global efforts to set standards for the identity, strength, quality, and purity of drugs, food ingredients, and dietary supplements.
In operation for over a decade, USP-India allows USP to pursue collaborative opportunities with policy makers, regulators, professional and manufacturing associations, and leaders in India's pharmaceutical and food sectors.
USP-India is ISO 17025 accredited and features state-of-the-art laboratories with analytical capability for the development of reference materials for all of USP’s compendia, including biologics research and synthetic chemistry.
USP-India also offers world class education and training for customers and stakeholders such as regulatory authorities, manufacturers, and students.